Back

The role of nutritional status, measured by serum albumin, as a prognostic factor in wild-type transthyretin amyloidosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Cardiac amyloidosis (1) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Santiago Decotto

Italian Hospital of Buenos Aires, Buenos Aires (Argentina)

9 More presentations in this session

Presentation thumbnail
Discussant - Cardiac amyloidosis (1)
Presentation thumbnail
Clinical characteristics and follow-up outcomes of patients with wild-type transthyretin amyloidosis: comparison of the pre- and post-bone scintigraphy eras in a Latin American center.
Miss P. Domenech (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Wild-type transthyretin cardiac amyloidosis: sex differences in prevalence, phenotype, and prognosis
Assistant Professor A. Zaroui (Creteil, FR)
Abstract Slides Video
Presentation thumbnail
Predictors of major adverse cardiovascular events in patients with wild-type transthyretin amyloid cardiomyopathy: insights from a regional hospital experience
Doctor A. Martins (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Real-world effectiveness of tafamidis in a contemporary, matched cohort of patients with variant and wild-type transthyretin amyloid cardiomyopathy
Doctor M. Maurer (New York, US)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Cardiac amyloidosis (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Beyond stability: unveiling the prognostic and therapeutic role of serum transthyretin in amyloid cardiomyopathy
thumbnail
Congress Presentation
Fluid status established by bioimpedance vector analysis (BIVA) at diagnosis of wild-type transthyretin amyloidosis is associated with patient survival
thumbnail
Congress Presentation
Beyond age - A prospective cohort study on the impact of frailty, malnutrition and disability on management and survival in transthyretin cardiac amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources